Lantheus Holdings, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Lantheus Holdings, Inc. (LNTH) had Common Stock, Capital Shares Reserved for Future Issuance of 4.21 million shares as of 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2021-02-25
- 2020-12-31: Common Stock, Capital Shares Reserved for Future Issuance 4.21M shares.
- 2020-09-30: Common Stock, Capital Shares Reserved for Future Issuance 4.21M shares.
- 2020-06-30: Common Stock, Capital Shares Reserved for Future Issuance 4.21M shares.
- 2017-04-30: Common Stock, Capital Shares Reserved for Future Issuance 250.00K shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2020-12-31 | 4.21M shares 10-K · filed 2021-02-25 |
| 2020-09-30 | 4.21M shares 10-Q · filed 2020-11-05 |
| 2020-06-30 | 4.21M shares 10-Q · filed 2020-07-31 |
| 2017-04-30 | 250.00K shares 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |